Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07095270 · ClinicalTrials.gov registry record · NA
Evaluation of Circadian OS Technology on Melatonin Suppression
A NA study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT07095270 is a NA study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 10 participants.
The verdict
NCT07095270, a NA study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
Primary Objective: Evaluate how the Circadian OS iPad-based light intervention suppresses melatonin. This small pilot study is designed to validate the Circadian OS technology by testing physiological response using melatonin suppression. The study aims to evaluate how the Circadian OS iPad-based light intervention influences sleepiness as measured objectively via suppression of melatonin and subjectively via the Karolinska Sleepiness scale.
Interventions
- DEVICE Circadian OS software
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2025-07-07 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07095270
The ClinicalTrials.gov registry entry for NCT07095270 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Circadian OS software is the first listed.
NCT07095270 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07095270 about?
NCT07095270 is a clinical study titled "Evaluation of Circadian OS Technology on Melatonin Suppression". Primary Objective: Evaluate how the Circadian OS iPad-based light intervention suppresses melatonin. This small pilot study is designed to validate the Circadian OS technology by testing physiological response using melatonin suppression. The study aims to evaluate how the Circadian OS iPad-based li...
What is the current status of trial NCT07095270?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2025-07-07. Estimated completion is 2025-12-31.
What interventions are being tested in trial NCT07095270?
The interventions under investigation include: Circadian OS software (DEVICE).
Who is sponsoring clinical trial NCT07095270?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.